Wells Fargo Initiates Oracle (ORCL) With Overweight, Sees Major AI Upside Ahead

By Ghazal Ahmed | December 06, 2025, 4:25 AM

Oracle Corporation (NYSE:ORCL) is one of the AI Stocks Analysts are Tracking Closely. On December 3, Wells Fargo initiated coverage of the stock with an “Overweight” rating and a $280 price target. Analysts at the firm view Oracle gaining major AI infrastructure share; supporting its long-term re-rating.

According to analyst Michael Turrin, Oracle is early at an AI-driven reacceleration; indicating meaningful upside even as shares sit “42% off highs” and valued at an estimated 25x FY27 earnings.

The company is well positioned to become a “clear market share gainer in infra,” with the potential to reach scale similar to the next closest hyperscaler by 2029.

Turrin noted how Oracle Cloud Infrastructure (OCI) is projected to scale sharply over the next four years, with cloud market share potentially rising to “~16% of the cloud market by 2029.”

"Clear market share gainer in infra: we see ORCL set to reach similar scale to next closest hyperscaler by 2029, underpinned by success landing numerous major AI infra projects (most notably OpenAI’s 4.5GW / $300B+ compute contract)… Our $280 PT is derived from 30x P/E on Fwd NTM ests, above historical levels but reasonable in our view given the magnitude of AI opp ahead and ORCL’s favorable positioning within key AI lab accounts.”

Oracle Corporation (NYSE:ORCL) is a database management and cloud service provider.

While we acknowledge the potential of ORCL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 AI Stocks Making Headlines on Wall Street and 10 AI Stocks in Focus This Week.

Disclosure: None.

Mentioned In This Article

Latest News

3 hours
5 hours
Dec-05
Dec-05
Dec-05
Dec-05
Dec-05
Dec-05
Dec-05
Dec-05
Dec-05
Dec-05
Dec-05
Dec-05
Dec-05